F9636
IgG−FITC from human serum
~20 mg/mL, buffered aqueous solution
Synonym(s):
IgG-Fluorescein isothiocyanate from human serum
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
conjugate
FITC conjugate
Quality Level
form
buffered aqueous solution
concentration
~20 mg/mL
storage temp.
2-8°C
target post-translational modification
unmodified
General description
IgGs are glycoprotein antibodies that regulate immunological defense mechanisms such as phagocytosis and inflammatory responses . IgG also modulates complement-mediated cell lysis . IgG-FITC from human serum does not react with purified human IgA, IgG, IgM, and Bence Jones κ and lambda myeloma proteins. Additionally, the product does not react with serum from rat, goat, rabbit, guinea pig, and mouse.
Application
IgG-FITC from human serum is suitable for use in immunoaffinity purifications , and metal-enhanced fluorescence . The product may also be used for immunoelectrophoretic applications.
Linkage
Do not confuse with Anti-Human IgG–FITC conjugate.
Physical form
Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage Class Code
12 - Non Combustible Liquids
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Selective nanopatterning of protein via ion-induced focusing and its application to metal-enhanced fluorescence.
Chang Gyu Woo et al.
Small (Weinheim an der Bergstrasse, Germany), 7(13), 1790-1794 (2011-05-14)
Purification of immunoglobulins from Serum Using Thiophilic Cellulose Beads
Subramanian, A.
International Journal of Biochromatography, 5(I), 31-47 (2000)
C I Bindon et al.
The Journal of experimental medicine, 168(1), 127-142 (1988-07-01)
Humanized antibodies are likely to have a major role in therapy and it is important to define their interaction with physiological effectors. By comparing a matched series of chimeric human mAbs we found that igG1 was most efficient in complement
Vishakha Sabharwal et al.
Infection and immunity, 77(3), 1121-1127 (2009-01-14)
Strategies to limit complement deposition on Streptococcus pneumoniae are established as virulence features for invasive disease, but their role in respiratory tract infection requires further analysis. We evaluated complement C3 protein deposition on discordant S. pneumoniae isolates of the same
Giovanni S Offeddu et al.
Small (Weinheim an der Bergstrasse, Germany), 15(46), e1902393-e1902393 (2019-09-10)
In vitro prediction of physiologically relevant transport of therapeutic molecules across the microcirculation represents an intriguing opportunity to predict efficacy in human populations. On-chip microvascular networks (MVNs) show physiologically relevant values of molecular permeability, yet like most systems, they lack
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service